Mixed
EPS of $7.67 rose 19%, while sales of $10.42B missed consensus near $10.72B. Mission Systems margin reached 16.7% and Defense Systems sales rose 14%. Full-year sales guidance fell to $41.7–41.9B, while EPS increased.
[AS-053]EPS of $7.67 rose 19%, while sales of $10.42B missed consensus near $10.72B. Mission Systems margin reached 16.7% and Defense Systems sales rose 14%. Full-year sales guidance fell to $41.7–41.9B, while EPS increased.
[AS-053]2025 sales were cut to $41.7–41.9B from $42.05–42.25B and EPS raised to $25.65–26.05; preliminary 2026 FCF was $3.1–3.5B.
[AS-053]The guide traded lower volume for better mix and margin, while preserving a 2026 cash inflection.
[AS-053]The slight decline reflected lower revenue and conversion quality despite stronger EPS.
[MKT-001]EPS of $7.67 rose 19%, while sales of $10.42B missed consensus near $10.72B. Mission Systems margin reached 16.7% and Defense Systems sales rose 14%. Full-year sales guidance fell to $41.7–41.9B, while EPS increased.
EPS of $7.67 rose 19%, while sales of $10.42B missed consensus near $10.72B.
Mission Systems margin reached 16.7% and Defense Systems sales rose 14%.
Full-year sales guidance fell to $41.7–41.9B, while EPS increased.
2025 sales were cut to $41.7–41.9B from $42.05–42.25B and EPS raised to $25.65–26.05; preliminary 2026 FCF was $3.1–3.5B.
| Metric | Prior | Latest | Consensus | Delta | Status | Reason / implication |
|---|---|---|---|---|---|---|
| 2025 sales | $42.05–42.25B | $41.7–41.9B | Not consistently available | -$0.35B midpoint | Lowered | Program timingLower Q4 delivery |
| 2025 EPS | Prior charge-adjusted range | $25.65–26.05 | Not consistently available | Raised | Raised | Mission and Defense marginsMix offsets lower sales |
| 2026 organic sales growth | No prior guide | Mid-single-digit | Not consistently available | Preliminary | New | Production rampsBacklog conversion accelerates |
| 2026 segment margin | No prior guide | Low-to-mid 11% | Not consistently available | Preliminary | New | MixBroadly stable |
| 2026 free cash flow | No prior guide | $3.1–3.5B | Not consistently available | Preliminary | New | Volume and working capitalCash inflection |
The environment supported 2026 growth and Defense Systems margins, but elevated capex and inventory delayed FCF conversion.
The guide traded lower volume for better mix and margin, while preserving a 2026 cash inflection.
The slight decline reflected lower revenue and conversion quality despite stronger EPS.
The stock fell about 1.2% on the first day.
| Window | Stock | vs benchmark | vs peers |
|---|---|---|---|
| 1D | -0.4% | -0.4% | +0.7% |
| 2D | -0.9% | -0.4% | +0.8% |
| 5D | -1.0% | -3.1% | -1.6% |
Unprecedented demand and international bookings strengthened, while capacity investment and a fourth-quarter inventory release kept cash conversion back-end-loaded.
"Unprecedented demand environment"; desire to "move quickly" not yet reflected in current reality
Book-to-bill 1.17x on $12.2bn net awards; backlog $91.4bn (+8% YoY); TTM 1.22x
International sales +32% in Q3, +20% YTD; strong bipartisan support and reconciliation funding
Aeronautics inventory liquidation a key driver of 4Q FCF and sequential revenue acceleration
Tactical SRM capacity "more than doubled"; breaking ground on another facility (~2 yrs); SRMs "not a constraint"
>4% of sales to capex over 2024–25; >$2bn IRAD over two years; rate not required for base book
"New entrants can come in. I'm not afraid of competition... our goal is to be positioned to take share now"
Shift toward more fixed-price contracts contributed to positive DS margin surprise; aiming to be "very price competitive" on SRMs
Consensus snapshots are reconstructed from contemporaneous broker notes; the flattened AlphaSense export does not preserve stable document URLs.
AlphaSense synthesis
Open source ↗Official company source
Open source ↗AlphaSense market-environment synthesis
Open source ↗